Aurora Cannabis Reports Strong FY26 Performance with Medical Sales Growth
Aurora Cannabis (ACB) reported a strong fiscal year 2026 performance, driven by an increase in medical cannabis sales and international revenue. The company's net revenue rose to C$320.6 million, up 11% from the previous year, with medical cannabis contributing significantly at 91% of total fourth-quarter revenue.
Tickers: $ACB $CGC $CRON $TLRY
Topics: cannabis international_expansion medical_cannabis_growth